SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-002544
Filing Date
2021-01-15
Accepted
2021-01-15 16:30:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea133391-s3_soligenixinc.htm S-3 340157
2 OPINION OF DUANE MORRIS LLP ea133391ex5-1_soligenixinc.htm EX-5.1 32801
3 CONSENT OF EISNERAMPER LLP ea133391ex23-1_soligenixinc.htm EX-23.1 2196
4 GRAPHIC img_001.jpg GRAPHIC 3505
5 GRAPHIC img_002.jpg GRAPHIC 14812
6 GRAPHIC ex5-1_001.jpg GRAPHIC 111456
7 GRAPHIC ex5-1_002.jpg GRAPHIC 109530
  Complete submission text file 0001213900-21-002544.txt   705360
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252153 | Film No.: 21532462
SIC: 2834 Pharmaceutical Preparations